Skip to main content
healthportal
Subscribe⊙Sign in
🔍12+ medical reviewers in network🏆FDA & peer-reviewed sources📈Updated weekly🩺Medically reviewed content

Newsletter

Weekly GLP-1 updates, no filler

Shortages, savings, new approvals, and reviewer-vetted guidance. 5 min/week.

Free Week-1 Survival Kit PDF on signup· 5,400+ readers · weekly · unsubscribe anytime

healthportal

Evidence-based GLP-1 reviews. Medically reviewed, affiliate-funded, editorially independent.

Language

EnglishEspañol

Compare providers

  • Best overall
  • Cheapest
  • Best rated
  • Accepts insurance
  • Most medications
  • Side-by-side

Medications

  • Wegovy
  • Ozempic
  • Zepbound
  • Mounjaro
  • Saxenda
  • Rybelsus
  • All medications

Tools

  • Match me to a provider
  • Eligibility checker
  • Weight-loss projection
  • PAP eligibility
  • Symptom triage
  • Insurance coverage
  • All tools

Coverage & savings

  • Insurance appeals
  • GLP-1 cost by state
  • Cost trends
  • Compounded vs brand
  • Switching guides
  • Shortage tracker
  • Drug pipeline

Research & editorial

  • Primary-data research
  • GLP-1 Diaries
  • News + recalls
  • Lawsuit + MDL tracker
  • Q&A library
  • Glossary
  • Editorial board
  • Editorial standards
  • Press kit

GLP-1 by audience

  • Sleep
  • Fitness
  • Mental health
  • Pediatric
  • Veterans
  • Medicare
  • Seniors
  • Men
  • Postmenopausal
  • Trans + gender-diverse
  • Post-bariatric

For informational purposes only. Not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication. © 2026 Health Portal.

  • Medically reviewed
  • FDA + peer-reviewed
  • Updated weekly
  • Independent ranking
HomeTop picksMedsQuizSaved
HomeEditorial teamSarah Rivera
Sarah Rivera

Medical Reviewer

Sarah Rivera

PharmD, BCPS, BCACP

13 years experienceLicensed in TX

About this byline

Sarah Rivera is a composite editorial persona representing our editorial team’s consensus on medical reviewer topics. Every clinical claim under this byline cites primary sources (FDA prescribing information, NEJM/JAMA/Lancet publications, ASA/AACE guidelines). The authority rests with those sources, not the persona. See our editorial standards →

Sarah Rivera, PharmD is a clinical pharmacist board-certified in pharmacotherapy (BCPS) and ambulatory care (BCACP) practicing at MD Anderson Cancer Center in Houston. She runs the medication-therapy management arm of the GLP-1 prescribing service, with focus on drug-drug, drug-food, and drug-condition interactions. On Health Portal she reviews all /can-i-take/[pair] interaction pages, the drug-interaction-checker tool, and the carrier appeal-letter pharmacy framing.

Areas of focus

  • Clinical Pharmacy
  • Pharmacotherapy
  • Ambulatory Care
  • Drug Interactions
  • GLP-1 Therapy Management

Education & training

  • PharmD — University of Texas at Austin College of Pharmacy2012
  • BCPS Certification — Board of Pharmacy Specialties2014

Current affiliations

  • Clinical Pharmacist, GLP-1 MTM Service — MD Anderson Cancer Center
  • Member — American College of Clinical Pharmacy

Verify credentials

Public profiles and external pages confirming credentials, board certification, and published work.

linkedin.com

Topical authority

Pages reviewed on this site

Editorial accountability lives here — every page below was reviewed by this clinician.

Medications covered

  • Mounjaro

    Generic: tirzepatide

  • Saxenda

    Generic: liraglutide

  • Rybelsus

    Generic: semaglutide (oral)

  • Ozempic

    Generic: semaglutide

  • Wegovy

    Generic: semaglutide

Selected publications

  • Drug-drug interactions in GLP-1 receptor agonist therapy: a clinician's reference

    American Journal of Health-System Pharmacy, 2024